Letter

High risk groups are still not being vaccinated

BMJ 2005; 330 doi: 10.1136/bmj.330.7484.198 (Published 20 January 2005)
Cite this as: BMJ 2005;330:198.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Adam R Winstock, area clinical director (Adam.Winstock@swsahs.nsw.gov.au)
  1. Drug Health Services, South Western Sydney Area Health Service, PO Box 39, Liverpool BC, NSW1871, Australia

    EDITOR—Aggarwal and Ranjan highlighted the global burden of hepatitis B and say that vaccination is the mainstay of prevention.1 They also describe the vaccination's lifelong efficacy and cost effectiveness. With such a clear evidence base and the recognition that certain high risk groups—such as injecting drug users—must be …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular